Genzyme comes up with cure
Framingham drug plant set after sewer problem resolved
Genzyme Corp. , one of the state's largest biotech companies, said it has resolved a sticky problem with Framingham's sewage system, allowing the Cambridge company to go ahead with plans to build a $260 million drug manufacturing plant there. (Full article: 594 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
